ovel tumor marker in white blood cells a highly sensitive and specific breast cancer biomarker
Phase 1
- Conditions
- Breast cancer,tumor markertumor marker,White blood cell
- Registration Number
- TCTR20180804002
- Lead Sponsor
- ational Research Council of Thailand (NRCT)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Enrolling by invitation
- Sex
- Female
- Target Recruitment
- 1000
Inclusion Criteria
Patients will be recruited healthy female without an immune disorder, chronic disease, family history of cancer and the negative result in colonoscopy examination.
For breast cancer patients, all cancer cases will be staged according to the revised TNM classification criteria by the pathologist.
Exclusion Criteria
Patients who have an immune disorder, chronic disease, family history of cancer and the positive result in colonoscopy examination.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ovel Tumor Marker for Breast Cancer Screening in Blood Sample 1 year Immunofluorescence staining
- Secondary Outcome Measures
Name Time Method ovel Laboratory Test for Breast Cancer Screening 1 year Immunofluorescence staining, Flow cytometry